NG Industries Ltd.

View in App
89.92 -0.60 ▼-0.7%

06 June 2023, 04:01:00 PM
Volume: 2,308

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.ngind.com
Market Cap 30.13 Cr.
Enterprise Value(EV) 28.98 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 24.82 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 3.62 Trailing Twelve Months Ending 2023-03
Industry PE 48.57 Trailing Twelve Months Ending 2023-03
Book Value / Share 84.17 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.07 Calculated using Price: 89.92
Dividend Yield 3.89 Period Ending 2022-03
No. of Shares Subscribed 0.34 Cr. 3,350,500 Shares
FaceValue 10
About NG Industries Ltd.
The company's principal activity is to provide healthcare and medical services. The company facilitates through the treatments and services like, imaging, cardiology, endoscopy, neurology, pathology, orthopaedics, infertility, surgery, operation theatres, indoor ward and surgery.

NG Industries Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

NG Industries Ltd. Performance

View details >>
1 Day
-0.66%
1 Week
+3.14%
1 Month
+12.55%
3 Month
+18.96%
6 Month
+12.05%
1 Year
+30.13%
2 Year
+92.14%
5 Year
+22.42%
10 Year
+49.87%

NG Industries Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.66 9.97 10.63 9.81 7.18 9.86 14.44 5.04 13.41
Return on Capital Employed (%) 13.62 12.93 15.93 14.33 11.81 14.94 17.80 6.57 17.19
Return on Assets (%) 8.03 8.32 9.10 8.17 6.35 9.59 12.71 4.38 11.96

NG Industries Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 14 14 14 14 12 11 9 15 24 28
Non Curr. Liab. 0 0 0 0 -2 -2 -2 -1 2
Curr. Liab. 3 3 3 3 2 2 5 2 2 3
Minority Int.
Equity & Liab. 18 17 17 18 12 11 12 16 27 31
Non Curr. Assets 15 15 15 15 10 9 9 14 22 28
Curr. Assets 3 2 2 3 2 3 2 3 5 3
Misc. Exp. not W/O
Total Assets 18 17 17 18 12 11 12 16 27 31

NG Industries Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 14 15 17 17 17 18 19 12 18 19
Other Income 1 1 0 0 0 0 0 0 2 8
Total Income 14 15 17 17 18 18 19 12 20 27
Total Expenditure -11 -12 -14 -15 -15 -15 -16 -11 -16 -17
PBIDT 3 3 3 3 2 2 3 1 4 10
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 0 -1 -1
Taxation -1 -1 -1 -1 -1 -1 -1 0 -1 -1
Exceptional Items
PAT 2 1 2 1 1 1 1 1 3 8
Adjusted EPS 5 4 5 4 3 3 4 2 8 25

NG Industries Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 2 2 2 2 2 4 3 1 -2
Cash Fr. Inv. -4 2 -1 -1 -1 -2 -1 -3 2 1
Cash Fr. Finan. 2 -4 -2 -1 -1 -2 -2 0 -3 0
Net Change 0 0 -1 0 0 -1 1 0 1 0
Cash & Cash Eqvt 2 2 1 1 1 0 1 1 2 1

NG Industries Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 74.50 74.50 74.50 74.50 74.50 74.50 74.50 74.50 74.50
Public 25.50 25.50 25.50 25.50 25.50 25.50 25.50 25.50 25.50
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

NG Industries Ltd. Announcements

View details >>
Fri, 19 May 2023
Board Meeting Outcome for Board Meeting Outcome For Audited Annual Financial Results Dividend And Related Matters
Board Meeting Outcome for Audited Annual Financial Results Dividend And Related Matters
Fri, 19 May 2023
Financial Results For Quarter And Year Ended 31St March 2023
Financial Results for Quarter and Year ended 31st March 2023
Fri, 19 May 2023
Corporate Action-Board approves Dividend
Board approves Dividend for the Financial year ended 31st March 2023 subject to approval of shareholders.

NG Industries Ltd. Technical Scans

View details >>
Tue, 06 Jun 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
S Making Lower Lows for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 1 Year High Increase in 1 Year

NG Industries Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,184.60 1,013.55 +0.4%
Divi's Laboratories Ltd. 93,886.95 3,536.65 +2.2%
Cipla Ltd. 78,522.76 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. 77,195.89 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. 71,115.89 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. 60,794.95 1,796.30 +1.2%
Mankind Pharma Ltd. 59,699.70 1,490.30 +4.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.70 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 51.49 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 28.02 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.13 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.83 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.83 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 44.71 1,490.30 +4.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.34 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.35 3,536.65 +2.2%
Cipla Ltd. Consolidated 2023-03 3.35 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.32 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.49 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.81 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 5.75 1,490.30 +4.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 0.04 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 13.10 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,490.30 +4.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,490.30 +4.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,013.55 +0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,536.65 +2.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 972.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,635.15 +0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,946.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,796.30 +1.2%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,490.30 +4.6%

NG Industries Ltd. FAQ's

What is NG Industries share price?
Can I buy NG Industries shares now?
What is the Dividend Yield of NG Industries?
What is the Market Cap of NG Industries?
What are the key metrics to analyse NG Industries?
What is the 52 Week High and Low of NG Industries?
What is the trend of NG Industries share price?